Gateway Analytical announced today that they will be exhibiting at the 14th Annual Contract Pharma 2015 Contracting and Outsourcing Conference in New Brunswick, New Jersey on September 17th and 18th. The conference is focused on helping to address challenges that today’s drug manufacturers face, such as the increasing pressure to grow and evolve beyond strategies of the past, understanding new technologies, heightened regulatory guidelines, and the continuous growth of generic products.
The Contract Pharma Conference offers educational and networking opportunities for industry leaders in the pharmaceutical and biopharmaceutical manufacturing. “This will be our first year exhibiting at the Contract Pharma Conference and we are looking forward to participating in the different regulatory and quality focused discussions,” said David Exline, Senior Vice President at Gateway Analytical. “We recognize that manufacturers often need analytical support at many different levels and with our wide range of technology and expertise in both common and specialized areas such as foreign particulate identification and glass delamination analysis, Gateway Analytical is in a good position to be able to support drug manufacturers throughout their entire process.”
During the conference, Gateway Analytical will be promoting a wide array of analytical testing services that focus on supporting pharmaceutical drug manufacturing quality control including particulate contamination identification, root cause analysis, glass delamination analysis, deviation, and out-of-specification investigation support. Of particular interest to conference attendees is Gateway Analytical’s ability to give preliminary results in as little as 24 hours with a final analytical report available in 48 hours in some cases.
Gateway Analytical is a full service, cGMP compliant, FDA registered and inspected laboratory with specialized expertise in techniques for chemically specific analysis and particulate contamination identification. For more information on Gateway Analytical pharmaceutical investigation services, contact Karen Sutch, Business Development Manager
